Core Viewpoint - Yongsheng Medical (01612) has issued a positive earnings forecast, leading to a stock price increase of over 9%, with the current price at 0.93 HKD and a trading volume of 5.704 million HKD [6]. Financial Performance - The company anticipates an unaudited consolidated profit attributable to shareholders of no less than 100 million HKD for the fiscal year ending December 31, 2025, compared to an audited profit of approximately 69.2 million HKD for the fiscal year ending December 31, 2024 [6][1]. - The expected profit increase is attributed to strengthened relationships with a major customer in the imaging disposable products segment and business expansion, which significantly boosts revenue [6][1]. Operational Efficiency - The company has achieved better economies of scale by enhancing capacity utilization and operational efficiency, leading to an improved gross profit margin [6][1].
永胜医疗盘中涨超9% 预期2025年度股东应占综合溢利不少于1亿港元